Assertion: lopinavir ritonavir | /r/HasProperty | effective
Facets:
value: in shortening the duration of virus
type: PURPOSE
value: highly
type: DEGREE
Source sentences:
text: It is important to know if lopinavir/ritonavir is effective for mild/moderate cases with COVID-19," Li says.
text: The researchers chose to study LPV/r and Arbidol because the antivirals had been selected as candidates for treating COVID-19 in a guidance issued on February 19, 2020, by the National Health Commission of China, based on in vitro cell tests and previous clinical data from SARS and MERS.Other researchers had already found that LPV/r did not improve outcomes for patients with severe COVID-19."It is important to know if lopinavir/ritonavir is effective for mild/moderate cases with COVID-19," Li says.
text: This study showed that early treatment with the triple combination of antiviral therapy with interferon beta-1b, lopinavir–ritonavir, and ribavirin is safe and highly effective in shortening the duration of virus shedding, decreasing cytokine responses, alleviating symptoms, and facilitating the discharge of patients with mild to moderate COVID-19.